![Julie Lautt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julie Lautt
Direktor/Vorstandsmitglied bei Alucent Biomedical Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Myles D. Greenberg | M | 56 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
James Corbett | M | 65 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Daniel Pelak | M | 72 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | 6 Jahre |
Pat Costello | M | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
David Flicek | M | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Ryan Hansen | M | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 6 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Julie Lautt
- Persönliches Netzwerk